CCM

Cutter Capital Management Portfolio holdings

AUM $230M
1-Year Est. Return 11.53%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+11.53%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$244M
AUM Growth
-$94.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$21.9M
2
+$18.8M
3
+$14.3M
4
AMGN icon
Amgen
AMGN
+$11.3M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$10.6M

Top Sells

1
+$30.1M
2
+$29.7M
3
+$17.9M
4
LEGN icon
Legend Biotech
LEGN
+$15.9M
5
LLY icon
Eli Lilly
LLY
+$15.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX icon
26
Arcellx
ACLX
$6.7B
– –
-89,863
AVDL
27
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-385,172
AXSM icon
28
Axsome Therapeutics
AXSM
$8B
– –
-105,767
BCRX icon
29
BioCryst Pharmaceuticals
BCRX
$2.34B
– –
-798,137
BMY icon
30
Bristol-Myers Squibb
BMY
$120B
– –
-574,057
ELVN icon
31
Enliven Therapeutics
ELVN
$2.32B
– –
-207,896
GILD icon
32
Gilead Sciences
GILD
$167B
– –
-359,025
HRMY icon
33
Harmony Biosciences
HRMY
$1.54B
– –
-376,315
IONS icon
34
Ionis Pharmaceuticals
IONS
$11.9B
– –
-97,300
IOVA icon
35
Iovance Biotherapeutics
IOVA
$1.45B
– –
-876,009
JAZZ icon
36
Jazz Pharmaceuticals
JAZZ
$11.2B
– –
-117,500
LEGN icon
37
Legend Biotech
LEGN
$3.11B
– –
-325,953
LLY icon
38
Eli Lilly
LLY
$785B
– –
-17,299
1
2